Australia, Jan. 13 -- ResQ Pharma Inc., owns the trademark (2597071) for 'RESQ PHARMA' till May 8, 2035.
Status: protected:
Registered/protected
Classes: 5 [Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and set for administering lipid emulsion to patients for medical purposes, all for use in treating anesthetic and drug toxicity; medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and set for administering lipid emulsion to patients for medical purposes, all for use in resuscitating patients; medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and set for administering lipid emulsion to patients for medical purposes, all for use in treating cardiac arrest due to ischemia and cardiac failure; syringes that are used for administering lipid emulsions in the nature of syringes sold filled with a pharmaceutical, namely, a lipid emulsion for use in treating anesthetic and drug toxicity, treating neurological toxicity, treating cardiac arrest due to ischemia, treating cardiac failure, treating cardiac toxicity, and for resuscitating patients.] and 10 [An empty medical syringe.]
Type of Mark: Word
Date of Acceptance: Nov. 5, 2025
Registration Advertised: Jan. 12
For further details contact Hillary E. Maynard Polsinelli PC.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2597071.
Disclaimer: Curated by HT Syndication.
